Jascayd
Imported from official source
Jascayd Active substance Nerandomilast Titulaire Boehringer Ingelheim International GmbH Holder Running Indication Treatment of adult patients with idiopathic pulmonary fibrosis Public documents Approbation Information for the patient Informed consent Last update 07/10/2026 valerie.coqu Wed, 10/07/2026 - 14:11
This version
- Version
- 1 of 1
- Recorded
- October 07, 2026 12:36
- Change
- Initial
- Content hash
efabbf5f9c9c40daa8b61f7684d1944a- All versions
- Revision history